



	Questions : Lok Sabha




























Screen Reader Access
Skip to Main Content
Skip to Navigation



Text Size

                                A

                                A
A















हिन्दी मे








Parliament of India Lok Sabha House of the
                        People






* Special Characters not allowed












India Time 


Your Time 


                        Tuesday,
                        12 April 2022









HomeMembersSitting MembersMembers Home PageMembers' PortalContact DetailsMembers SearchStatistical AnalysisAttendance of MembersHandbook Members Since 1952Digitized Who's WhoOthers BusinessProvisional CalendarList of BusinessPapers to be LaidList of Private Members' BusinessBulletin-IDigitized Lok Sabha Bulletin Part IBulletin-IIStatement of WorkSpecial Mentions (ZERO HOUR)Resume of WorkDigitized Resume of Work done by Lok Sabha QuestionsHomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions DebatesIntroductionSynopsisUncorrected DebateText of DebateDigitized DebatesConstituent Assembly DebatesWit And HumourDebate SearchHindi FontsDisclaimer Papers LaidPapers Laid on the Table of the House LegislationIntroduction(How Bill Becomes Act)Bills IntroducedBills PassedBills PendingBills AssentedBills LapsedBills WithdrawnBills NegativedBills Search Disclaimer CommitteesIntroductionChairpersonSummary of WorkCommittee Meetings ScheduleBills Referred to CommitteesReports PresentedDigitized ReportsPress ReleaseMembership SearchToday's Committee MeetingsCommittee Subject SelectedDepartment Related-RS Govt. AssurancesSANSAD TVIntranet





HomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions











Download as PDF




Print












PDF/WORD(Hindi)


PDF/WORD




                                    GOVERNMENT OF INDIA
                                





                                    MINISTRY OF
                                    SCIENCE AND TECHNOLOGY






                                    LOK SABHA
                                





UNSTARRED 


                                    QUESTION NO:
                                

4471






                                    ANSWERED ON: 
                                

30.03.2022






Genome and DNA Sequencing




Manoj Rajoria














                        Will the Minister of





SCIENCE AND TECHNOLOGY


                        be pleased to state:-















                                                    (a) the current status of the genome and DNA sequencing of COVID-19 in the country;(b) the list of the total number of bio-repositories fixed by the Government for COVID-19; and(c) the details of the efforts being made by the Government for the development of biotechnology in the country in view of the circumstances arising out of COVID-19 in future?






ANSWER




                                                        MINISTER OF STATE (INDEPENDENT CHARGE) OFSCIENCE AND TECHNOLOGY AND EARTH SCIENCES(DR. JITENDRA SINGH)??????? ?? ???????????? ??? ?????? ??????? ?? ????? ?????? (???????? ??????) (??. ????????? ????)(a)	Sir, the Indian SARS-CoV-2 Genomics Consortium (INSACOG) being coordinated by the Department of Biotechnology (DBT), as on 23rd March 2022 has sequenced 2,01,373 SARS-CoV-2 genomes.(b)	A total of 17 COVID-19 Bio-repositories have been notified by the Government of India. These are set up at laboratories of Department of Biotechnology (DBT), Council of Scientific & Industrial Research (CSIR) and Indian Council of Medical Research (ICMR). These COVID-19 Bio-repositories established at:1. ICMR-National Institute of Virology, Pune2. ICMR-National Institute of Virology Field Unit, Bangalore3. ICMR-National Institute of Virology Field Unit, Kerala4. ICMR- National Institute of Cholera and Enteric Diseases, Kolkata5. ICMR-National Institute for Implementation Research on Non-Communicable Diseases, Jodhpur6. ICMR- National Institute of Malaria Research, Delhi7. ICMR- National Institute of Epidemiology, Chennai8. ICMR- National Institute for Research in Reproductive Health, Mumbai9. ICMR-Regional Medical Research Centre, Dibrugarh10. NCR Biotech Science Cluster Translational Health Science and Technology Institute and Regional Centre for Biotechnology, Faridabad11. Institute of Life Sciences, Bhubaneswar12. Institute for Stem Cell Science and Regenerative Medicine, Bengaluru13. National Centre for Cell Science, Pune14. DBT funded Biorepository – Institute of Liver and Biliary Sciences, New Delhi15. CSIR- Institute of Genomics and Integrative Biology, New Delhi16. CSIR- Centre for Cellular & Molecular Biology, Hyderabad17. CSIR - Institute of Microbial Technology, Chandigarh(c)	The Department of Biotechnology (DBT), based on extensive scientific deliberations, initiated an integrated response to overcome the unprecedented COVID-19 pandemic, in alignment with R&D Blueprint of the World Health Organization (WHO). DBT along with its public sector undertaking Biotechnology Industry Research Assistance Council (BIRAC) launched ‘DBT-BIRAC COVID-19 Research Consortium’ whereby, Research and Development projects were supported across the thematic areas of vaccines and supporting ecosystem, diagnostics and facilities for scale-up, therapeutics, drug repurposing & supporting ecosystem, and other biomedical interventions. The Indian SARS-CoV-2 Genomics Consortium (INSACOG) started jointly by Department of Biotechnology and Ministry of Health and Family Welfare in collaboration with Council of Scientific and Industrial Research and Indian Council of Medical Research with primary aim to expand whole genome sequencing of SARS-CoV-2 virus across the nation. Under National Biopharma Mission and Mission COVID Suraksha, the Department has enabled support for pre-clinical development of COVID-19 vaccine candidates and scale-up of manufacturing of COVID-19 diagnostic kits, facilities for animal challenge studies, facilities for immunogenicity assays, clinical trial sites etc.  *****
























HomeArchiveIndex to Select Questions (1984-1999)Ballot ListStatistical Statements Relating to QuestionsUploading of Questions - Status QueryProcedure for Sending Text of Questions & AnswersDemarcation of responsibilities in Govt. of IndiaBrochure on Statutory Corporations, Companies and Other Bodies in Which the Government of India have financial or controlling interestHighlights pertaining to questions of 17th Lok Sabha






Contact Us 
Disclaimer











        Developed and Hosted by National Informatics Centre (NIC)

Content on this website is published,
            managed & maintained by Software Unit, Computer (HW & SW) Management. Branch,
            Lok Sabha Secretariat





HomeMembersBusinessQuestionsDebatesPapers Laid


LegislationCommitteesSANSAD TVIntranetSecretariatPRIDE


RecruitmentSC/ST ReservationConferenceParliament Library


About ParliamentPhoto GalleryRelated LinksRTITendersFAQ


SpeakerDy. SpeakerLeader of the HousePanel of ChairpersonsContact UsFeedback


Council of MinistersPublications of MinistriesParliamentry ProceduresJournal of Parliamentary Information
Visitor's Counter:113263881







Copyright
Privacy Policy
Disclaimer
Terms &
                Conditions

                Accessibility Statement
Accessibility
                Options
Feedback
Site Map







